These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1826278)

  • 41. [Value of cyproterone acetate in the treatment of hirsutism].
    Baron J; Chwalisz K; Warenik-Szymankiewicz A
    Ginekol Pol; 1982 Apr; 53(4):283-7. PubMed ID: 6216148
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate].
    Frank-Raue K; Junga G; Raue F; Vecsei P; Ziegler R
    Klin Wochenschr; 1990 Jun; 68(12):597-601. PubMed ID: 2142968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS; Shearman RP; Allen JK; McCarron G
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acceptability, tolerance and quality of life impact of cyproterone acetate treatment in female hirsutism. Comparison of 2 protocols in combination with oral or transdermal estradiol].
    Consoli SM; Vexiau P; Consoli SG; Abramovici Y
    Contracept Fertil Sex; 1994 Dec; 22(12):783-7. PubMed ID: 7827642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.
    Gökmen O; Senöz S; Gülekli B; Işik AZ
    Gynecol Endocrinol; 1996 Aug; 10(4):249-55. PubMed ID: 8908525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Female hirsutism: pathophysiological considerations and therapeutic implications.
    Biffignandi P; Massucchetti C; Molinatti GM
    Endocr Rev; 1984; 5(4):498-513. PubMed ID: 6094172
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
    Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
    Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM; Jha A
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G; Sas M
    Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
    Lumachi F; Rondinone R
    Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.
    Grigoriou O; Papadias C; Konidaris S; Antoniou G; Karakitsos P; Giannikos L
    Gynecol Endocrinol; 1996 Apr; 10(2):119-23. PubMed ID: 8701785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of hirsutism and acne with cyproterone acetate.
    Miller JA; Jacobs HS
    Clin Endocrinol Metab; 1986 May; 15(2):373-89. PubMed ID: 2941191
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
    Lunell NO; Zador G; Carlström K; Eneroth P; Patek E; Wager J
    Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical results and hormonal aspects of the treatment of virilizing symptoms in women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Sogn J; Stafsnes H
    Wien Klin Wochenschr; 1979 Feb; 91(4):126-30. PubMed ID: 154778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.